Bioadsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery

被引:385
|
作者
Sheridan, MH
Shea, LD
Peters, MC
Mooney, DJ [1 ]
机构
[1] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA
关键词
angiogenesis; poly (lactide-co-glycolide); alginate; tissue engineering; vascular endothelial growth factor;
D O I
10.1016/S0168-3659(99)00138-8
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Engineering new tissues utilizing cell transplantation on biodegradable polymer matrices is an attractive approach to treat patients suffering from the loss or dysfunction of a number of tissues and organs. The matrices must maintain structural integrity during the process of tissue formation, and promote the vascularization of the developing tissue. A number of molecules (angiogenic factors) have been identified that promote the formation of new vascular beds from endothelial cells present within tissues, and the localized, controlled delivery of these factors from a matrix may allow an enhanced vascularization of engineered tissues. We have developed a gas foaming polymer processing approach that allows the fabrication of three-dimensional porous matrices from bioabsorbable materials (e.g., copolymers of lactide and glycolide [PLG]) without the use of organic solvents or high temperatures. The effects of several processing parameters (e.g., gas type, polymer composition and molecular weight) on the process were studied. Several gases (CO2, N-2, He) were utilized in the fabrication process, but only CO2 resulted in the formation of highly porous, structurally intact matrices. Crystalline polymers (polylactide and polyglycolide) did not form porous matrices, while amorphous copolymers (50:50, 75:25, and 85:15 ratio of lactide:glycolide) foamed to yield matrices with porosity up to 95%. The mechanical properties of matrices were also regulated by the choice of PLG composition and molecular weight. Angiogenic factors (e.g., vascular endothelial growth factor) were subsequently incorporated into matrices during the fabrication process, and released in a controlled manner. Importantly, the released growth factor retains over 90% of its bioactivity, In summary, a promising system for the incorporation and delivery of angiogenic factors from three-dimensional, biodegradable polymer matrices has been developed, and the fabrication process allows incorporation under mild conditions. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:91 / 102
页数:12
相关论文
共 50 条
  • [21] Controlled growth factor delivery for tissue engineering
    Lee, KY
    Mooney, DJ
    ADVANCES IN CONTROLLED DRUG DELIVERY: SCIENCE, TECHNOLOGY, AND PRODUCTS, 2003, 846 : 73 - 83
  • [22] Controlled Multiple Growth Factor Delivery from Bone Tissue Engineering Scaffolds via Designed Affinity
    Suarez-Gonzalez, Darilis
    Lee, Jae Sung
    Diggs, Alisha
    Lu, Yan
    Nemke, Brett
    Markel, Mark
    Hollister, Scott J.
    Murphy, William L.
    TISSUE ENGINEERING PART A, 2014, 20 (15-16) : 2077 - 2087
  • [23] Microporous silk fibroin scaffolds embedding PLGA microparticles for controlled growth factor delivery in tissue engineering
    Wenk, Esther
    Meinel, Anne J.
    Wildy, Sarah
    Merkle, Hans P.
    Meinel, Lorenz
    BIOMATERIALS, 2009, 30 (13) : 2571 - 2581
  • [24] Fabricating Tissue Engineering Scaffolds for Simultaneous Cell Growth and Drug Delivery
    Chen, Wenhui
    Tabata, Yasuhiko
    Tong, Yen Wah
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (21) : 2388 - 2394
  • [25] BIODEGRADABLE POLYMER SCAFFOLDS FOR TISSUE ENGINEERING
    FREED, LE
    VUNJAKNOVAKOVIC, G
    BIRON, RJ
    EAGLES, DB
    LESNOY, DC
    BARLOW, SK
    LANGER, R
    BIO-TECHNOLOGY, 1994, 12 (07): : 689 - 693
  • [26] Synthetic polymer scaffolds for tissue engineering
    Place, Elsie S.
    George, Julian H.
    Williams, Charlotte K.
    Stevens, Molly M.
    CHEMICAL SOCIETY REVIEWS, 2009, 38 (04) : 1139 - 1151
  • [27] Geometry as a Factor for Tissue Growth: Towards Shape Optimization of Tissue Engineering Scaffolds
    Bidan, Cecile M.
    Kommareddy, Krishna P.
    Rumpler, Monika
    Kollmannsberger, Philip
    Fratzl, Peter
    Dunlop, John W. C.
    ADVANCED HEALTHCARE MATERIALS, 2013, 2 (01) : 186 - 194
  • [28] Polymeric growth factor delivery strategies for tissue engineering
    Chen, RR
    Mooney, DJ
    PHARMACEUTICAL RESEARCH, 2003, 20 (08) : 1103 - 1112
  • [29] Advances in Growth Factor Delivery for Bone Tissue Engineering
    Oliveira, Erica Resende
    Nie, Lei
    Podstawczyk, Daria
    Allahbakhsh, Ahmad
    Ratnayake, Jithendra
    Brasil, Dandara Lima
    Shavandi, Amin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (02) : 1 - 33
  • [30] Polymeric Growth Factor Delivery Strategies for Tissue Engineering
    Ruth R. Chen
    David J. Mooney
    Pharmaceutical Research, 2003, 20 : 1103 - 1112